Neumora Therapeutics (NMRA) Shares Issued (2022 - 2025)

Neumora Therapeutics has reported Shares Issued for 4 years, with the latest figure at -$59000.0 in Q3 2025.

• For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to -$59000.0; the trailing twelve-month figure through Sep 2025 stood at $7.5 million (down 96.75% YoY), and the FY2024 full-year result was $7.5 million, down 96.78% from the prior year.
• Shares Issued for Q3 2025 stood at -$59000.0, down from $59000.0 in the prior quarter.
• The five-year high for Shares Issued was $230.0 million in Q4 2023, with the low at -$1.8 million in Q2 2024.
• Average Shares Issued over 4 years is $23.9 million, with a median of $503000.0 recorded in 2023.
• Year-over-year, Shares Issued soared 23035.99% in 2023 and slumped 556.68% in 2024.
• Tracing NMRA's Shares Issued over 4 years: stood at -$1.0 million in 2022, then soared by 23035.99% to $230.0 million in 2023, then tumbled by 96.75% to $7.5 million in 2024, then slumped by 100.79% to -$59000.0 in 2025.
• The last three Shares Issued figures came in at -$59000.0 (Q3 2025), $59000.0 (Q2 2025), and $7.5 million (Q4 2024), per Business Quant data.

Peer Comparison